Tech Company Financing Transactions
QuantomiX Funding Round
Pitango Venture Capital and Vitalife Life Sciences Venture invested in a $3.5 million Series B funding round for QuantomiX. The financing was announced on 8/14/2003.
Transaction Overview
Company Name
Announced On
8/14/2003
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Series B
Investors
Vitalife Life Sciences Venture (Jeffrey Dykan)
Proceeds Purpose
The platform, now at the Beta development stage in leading research institutes in the US and Israel, is set to be marketed first in the US and then in Europe and Japan.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
12 Hamada St.
Rehovot, 76703
Israel
Rehovot, 76703
Israel
Phone
Website
Email Address
Overview
QuantomiX develops and commercializes breakthrough solutions based on its proprietary WETSEMTM Technology. This technology enables scanning electron microscopes (SEM) to image and analyze wet samples such as cells, tissue biopsies, foods and ink, in their native environment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ori Zik
Browse more venture capital transactions:
Prev: 8/13/2003: Reactivity venture capital transaction
Next: 8/15/2003: Endocyte venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. All VC database entries reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs